While these findings suggest that propranolol enhances anti-tumor immunity and counteracts immunosuppression, these studies were conducted in young mice, leaving the effects of β-AR blockade on aged immune cells largely unexplored. The gene discussed is ADRB2; the disease is neoplasm.